Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1999
10/07/1999CA2291780A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0947584A1 Loxoprofen-containing preparation for external use
10/06/1999EP0947491A1 Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
10/06/1999EP0947489A1 Method of production of ceramics
10/06/1999EP0947244A1 Solubilizers, emulsifiers and dispersants
10/06/1999EP0947201A1 Pharmaceutical composition of hedgehog proteins and use thereof
10/06/1999EP0947200A2 Compositions comprising Cetrorelix acetate for the treatment of female infertility and gonadal protection
10/06/1999EP0947199A1 Composition comprising micro-encapsulated iron
10/06/1999EP0947197A1 Method for producing water dispersible sterol formulations
10/06/1999EP0947196A1 Sustained-release prostaglandin i derivative preparation
10/06/1999EP0947194A1 Dosage form comprising solid salts of R-alpha-lipoic acid with improved bioavailability
10/06/1999EP0947193A2 Percutaneously applicable preparation and suppository containing an antidementia medicament
10/06/1999EP0947188A2 Dividable tablet and press-through pack
10/06/1999EP0946637A1 Polymer film compositions for capsules
10/06/1999EP0946624A1 Biodegradable targetable microparticle delivery system
10/06/1999EP0946621A1 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair
10/06/1999EP0946223A1 Plasticizable implant material
10/06/1999EP0946221A1 Combatting infection in delivery systems
10/06/1999EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
10/06/1999EP0946197A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
10/06/1999EP0946193A1 Stabilizers for lyophilized vaccines
10/06/1999EP0946187A1 Coated compositions containing polyene derivatives
10/06/1999EP0946184A2 Novel formulations for the administration of fluoxetine
10/06/1999EP0946169A2 Method of producing a sustained-release preparation
10/06/1999EP0946161A1 Sustained release pharmaceutical tablets with tramadol base and their preparation
10/06/1999EP0946159A1 An oil composition of dihydropolyprenols
10/06/1999EP0946156A2 Therapeutic agents
10/06/1999EP0946155A1 Pharmaceutical composition for treating fecal incontinence and anal itch
10/06/1999EP0946154A1 Liquisolid systems and methods of preparing same
10/06/1999EP0946153A1 Homogeneously charged particulate vector and pharmaceutical or cosmetic composition containing same
10/06/1999EP0946152A1 Biodegradable capsule with a prolamin base
10/06/1999EP0946151A1 Ascending-dose dosage form
10/06/1999EP0946150A1 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium
10/06/1999EP0946149A1 Homogeneous preformulations containing wigh concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations
10/06/1999EP0946148A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
10/06/1999EP0946147A1 Treatment of equine laminitis
10/06/1999EP0946146A2 New aqueous medicament preparations for the production of propellent gas-free aerosols
10/06/1999EP0946145A2 Antitussive drugs delivered by ion exchange resins
10/06/1999EP0946144A1 Polymeric foam reservoirs for an electrotransport delivery device
10/06/1999EP0946143A2 A nitroimidazole gel composition
10/06/1999EP0946139A1 Pharmaceutical formulation
10/06/1999EP0946125A1 Device for stretching the crystalline capsule, capable of being charged with at least one active principle and for releasing said active principle, and its preparation
10/06/1999EP0804160B1 Compositions for applying active substances to or through the skin
10/06/1999EP0660705B1 Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
10/06/1999EP0527942B1 Colonic drug delivery system
10/06/1999CN1230890A Injectable formulations of avermectins and milbemycins
10/06/1999CN1230883A Coated particle formulation
10/06/1999CN1230882A Method and composition for rewetting contact lenses and relieving eye dryness
10/06/1999CN1230437A Process for producing solid dosage forms
10/06/1999CN1230429A Medicine for trachitis and its preparation
10/06/1999CN1230428A Dankang granule and its preparation
10/06/1999CN1230405A Composite blood compatible polymer/liquid crystal film and its preparation
10/06/1999CN1230404A Disinfecting chewing gum
10/06/1999CN1230403A Slow-releasing Chinese medicine capsule and its preparation
10/06/1999CN1230402A Production of composite preparation of bone morphogenesis protein and collagen particle
10/06/1999CN1230401A Compound non-opium drug abstaining spray
10/06/1999CN1230400A Composition and production process of recombined human interferon Alpha 2a as suppository matrix
10/06/1999CN1045472C Technology for extracting polyose protein from mushroom using enzyme process and producing polyose protein capsule
10/06/1999CN1045440C Process for preparing medicinal preparation containing beta-form thiamine hydrochloride crystals
10/05/1999US5962737 2-amino-1-phenylpropanols, stereospecific synthesis thereof, and method of optically resolving the same
10/05/1999US5962566 Drug delivery; sustained release; homogeneity blend of polyester, polyether, drug and preservative
10/05/1999US5962536 Injectable propofol formulations
10/05/1999US5962528 Administering uretha
10/05/1999US5962512 Oil containing 5-methoxypsoralen at a concentration of 60-100 ppm, and its use in treatment of psoriasis
10/05/1999US5962494 Methods for treating behavioral and other disorders using optically pure R(+) ondansetron
10/05/1999US5962461 Mixture of polyvinylpyrrolidone, polyol and ammonium glycyrrhizinate
10/05/1999US5962433 Topical composition containing hyaluronic acid and NSAIDS
10/05/1999US5962432 Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
10/05/1999US5962427 Targeting, transferring dna into mammalian repair cells
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962405 Storage-stable fibrinogen preparations
10/05/1999US5962310 Vehicle for delivery of particles to a sample
10/05/1999US5962048 Veterinary pharmaceutical method of administration
10/05/1999US5962024 Peroral composition for controlled release in the lower gastrointestinal tract
10/05/1999US5962023 Hydrogels containing absorbable polyoxaamides
10/05/1999US5962022 Tablet comprising a chewable base, nabumetone and an effervescent component comprised of an acid component and an alkaline component, wherein the nabumetone comprises at least 50% by weight of said tablet.
10/05/1999US5962021 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
10/05/1999US5962019 Alkanol solvent of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant.
10/05/1999US5962018 Microsphere formed of a non-polar copolymer of a carbamate and an acrylate
10/05/1999US5962017 Pharmaceutical compositions comprising cyclosporins
10/05/1999US5962016 Multivesicular liposomes utilizing neutral lipids to modify in vivo release
10/05/1999US5962015 Stabilized liposomes
10/05/1999US5962014 Hydrophilic component other than the hydrophilic surfactant, lipophilic component and hydrophilic surfactant other than the hydrophilic component; upon dilution with water an oil-in-water microemulsion is formed.
10/05/1999US5962013 Monolithic matrix transdermal delivery system for administering molsidomine
10/05/1999US5962012 Cholinergic antagonist patch
10/05/1999US5962010 Methods and compositions for treating dermatoses
10/05/1999US5962008 Topical medicament for use in treatment of anorectal inflammation
10/05/1999US5961988 Barium or strontium hexaferrite single crystals, samarium-cobalt particles and neodymium-iron-boron particles; aggregates consist of fluorocarbons and natural phospholipids with a phosphatidylcholine content of 30 to 99 wt %.
10/05/1999US5961970 Submicron emulsions as vaccine adjuvants
10/05/1999US5961969 Enhancing natural killer cell cytotoxicity.
10/05/1999US5961958 Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
10/05/1999US5961492 Fluid delivery device with temperature controlled energy source
10/05/1999US5961483 Iontophoretic delivery of cell adhesion inhibitors
10/05/1999US5961482 Iontotherapeutic device and process and iontotherapeutic unit dose
10/05/1999US5961459 Use of hollow microcapsules in diagnosis and therapy
10/05/1999CA2151574C Capillary composition containing an aqueous polymer dispersion
10/05/1999CA2115884C Water-in-oil emulsion for use in cosmetics or in pharmaceutics
09/1999
09/30/1999WO1999049858A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
09/30/1999WO1999048902A1 Azt derivatives exhibiting spermicidal and anti-viral activity
1 ... 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 ... 2991